Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹198Cr
Rev Gr TTM
Revenue Growth TTM
31.36%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

DAICHI
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 35.8 | -27.2 | -35.5 | -27.8 | -21.3 | 21.5 | 4.8 | 15.4 | 109.8 | 16.5 | 16.4 | -7.1 |
| 37 | 28 | 33 | 33 | 31 | 32 | 35 | 38 | 62 | 38 | 41 | 38 |
Operating Profit Operating ProfitCr |
| 12.0 | -2.1 | 4.7 | 7.0 | 8.3 | 5.7 | 4.7 | 6.7 | 11.5 | 3.2 | 4.2 | -0.8 |
Other Income Other IncomeCr | 1 | 1 | 21 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 1 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 |
| 3 | -3 | 20 | 0 | 1 | 0 | 0 | 3 | 7 | -1 | 1 | -2 |
| 4 | 0 | 5 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 1 | -1 |
|
Growth YoY PAT Growth YoY% | 74.7 | -29.2 | 21.4 | -93.4 | 317.4 | 90.8 | -102.5 | 223.7 | 391.0 | -88.9 | 8.1 | -178.5 |
| -1.1 | -10.5 | 42.3 | 1.7 | 3.0 | -0.8 | -1.0 | 4.7 | 7.0 | -1.3 | -0.8 | -4.0 |
| 0.8 | -3.9 | 19.6 | 1.5 | 1.5 | 0.6 | -0.3 | 3.5 | 8.3 | 0.0 | 0.0 | -1.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 22.8 | 7.1 | -35.0 | 16.6 | -37.1 | 16.1 | -9.1 | 25.1 | 51.0 | -28.5 | 37.9 | 4.8 |
| 159 | 162 | 109 | 132 | 103 | 112 | 111 | 140 | 168 | 125 | 167 | 179 |
Operating Profit Operating ProfitCr |
| 12.2 | 16.6 | 13.9 | 10.4 | -11.7 | -4.7 | -13.9 | -15.1 | 8.6 | 4.8 | 8.0 | 5.7 |
Other Income Other IncomeCr | 15 | 4 | 12 | 6 | 2 | 0 | 87 | 8 | 17 | 24 | 6 | 5 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 7 | 10 | 9 | 1 | 3 | 3 | 2 | 1 |
Depreciation DepreciationCr | 5 | 2 | 2 | 4 | 8 | 9 | 9 | 7 | 7 | 9 | 10 | 10 |
| 32 | 34 | 27 | 16 | -24 | -25 | 56 | -18 | 22 | 18 | 8 | 4 |
| 9 | 12 | 7 | 4 | -12 | 0 | 7 | 0 | 4 | 5 | 2 | 2 |
|
| 49.2 | -6.1 | -4.5 | -42.6 | -205.4 | -97.5 | 294.2 | -137.7 | 201.1 | -27.0 | -54.2 | -58.6 |
| 12.9 | 11.3 | 16.6 | 8.2 | -13.7 | -23.3 | 49.7 | -15.0 | 10.0 | 10.3 | 3.4 | 1.4 |
| 31.3 | 29.3 | 33.4 | 18.4 | -16.9 | -30.8 | 68.0 | -24.2 | 26.9 | 18.6 | 12.1 | 7.2 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| 101 | 119 | 142 | 151 | 135 | 112 | 163 | 142 | 162 | 173 | 181 | 178 |
Current Liabilities Current LiabilitiesCr | 36 | 30 | 23 | 54 | 64 | 80 | 66 | 58 | 58 | 39 | 42 | 37 |
Non Current Liabilities Non Current LiabilitiesCr | 3 | 2 | 6 | 63 | 75 | 70 | 2 | 7 | 20 | 3 | 3 | 3 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 108 | 106 | 91 | 100 | 72 | 74 | 93 | 68 | 68 | 53 | 70 | 68 |
Non Current Assets Non Current AssetsCr | 39 | 54 | 88 | 176 | 209 | 196 | 146 | 146 | 179 | 169 | 162 | 157 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 5 | 11 | 3 | -8 | 6 | 1 | -22 | -3 | 23 | 10 | 16 |
Investing Cash Flow Investing Cash FlowCr | 0 | -8 | -7 | -57 | -21 | 1 | 130 | -4 | -33 | 16 | -4 |
Financing Cash Flow Financing Cash FlowCr | -3 | -6 | 2 | 66 | 16 | -6 | -97 | -2 | 13 | -25 | -10 |
|
Free Cash Flow Free Cash FlowCr | -9 | 0 | -19 | -90 | -32 | -1 | 109 | -14 | -10 | 5 | 14 |
| 23.4 | 50.3 | 12.4 | -64.9 | -49.3 | -3.9 | -44.5 | 18.7 | 125.5 | 74.6 | 260.8 |
CFO To EBITDA CFO To EBITDA% | 24.7 | 34.3 | 14.9 | -51.0 | -57.5 | -18.9 | 159.0 | 18.6 | 145.9 | 159.9 | 111.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 117 | 260 | 370 | 295 | 153 | 130 | 222 | 272 | 270 | 380 | 177 |
Price To Earnings Price To Earnings | 5.1 | 12.8 | 14.8 | 21.6 | 0.0 | 0.0 | 4.4 | 0.0 | 13.4 | 27.4 | 19.7 |
Price To Sales Price To Sales | 0.7 | 1.3 | 2.9 | 2.0 | 1.7 | 1.2 | 2.3 | 2.2 | 1.5 | 2.9 | 1.0 |
Price To Book Price To Book | 1.1 | 2.1 | 2.5 | 1.9 | 1.1 | 1.1 | 1.3 | 1.8 | 1.6 | 2.1 | 0.9 |
| 4.8 | 7.8 | 21.1 | 23.5 | -21.6 | -42.9 | -16.7 | -15.7 | 18.9 | 62.5 | 12.4 |
Profitability Ratios Profitability Ratios |
| 37.0 | 41.1 | 39.5 | 35.5 | 31.3 | 33.3 | 30.9 | 26.8 | 35.6 | 40.3 | 35.8 |
| 12.2 | 16.6 | 13.9 | 10.4 | -11.7 | -4.7 | -13.9 | -15.1 | 8.6 | 4.8 | 8.0 |
| 12.9 | 11.3 | 16.6 | 8.2 | -13.7 | -23.3 | 49.7 | -15.0 | 10.0 | 10.3 | 3.4 |
| 29.9 | 26.7 | 18.0 | 7.2 | -7.5 | -7.0 | 34.1 | -9.8 | 12.1 | 10.7 | 5.1 |
| 21.5 | 17.3 | 13.9 | 7.5 | -8.8 | -20.8 | 28.4 | -12.2 | 10.9 | 7.5 | 3.3 |
| 15.8 | 13.7 | 11.7 | 4.3 | -4.5 | -9.2 | 20.3 | -8.5 | 7.5 | 6.1 | 2.7 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Dai-ichi Karkaria Limited is a pioneering Indian specialty chemical manufacturer established in **1963** in technical collaboration with **Dai-ichi Kogyo Seiyaku (Japan)**. The company has evolved into a high-performance entity focused on custom formulations and specialty surfactants. Operating as a single-segment entity, it leverages deep technical expertise to serve critical industrial sectors including Energy, Agrochemicals, and Personal Care.
---
### **Strategic Manufacturing Infrastructure & Capacity Expansion**
The company’s operational backbone consists of two primary manufacturing sites and a corporate headquarters in **Mumbai**. Following a period of reconstruction after a major fire in 2020, the company has transitioned into a phase of aggressive capacity restoration and modernization.
| Facility | Location | Strategic Focus & Recent Developments |
| :--- | :--- | :--- |
| **Dahej Plant** | Bharuch, Gujarat | Primary site for **Ethoxylation** and **PPD** (Pour Point Depressants). Recently modified into a **multi-purpose plant** to mitigate cyclicality. |
| **Kurkumbh Plant** | Pune, Maharashtra | Focuses on specialty formulations; maintains a stable workforce of **178 employees**. |
* **Ethoxylation De-bottlenecking:** The Ethoxylation unit is currently operating at **100% capacity**. To address this, a new reactor is under installation and scheduled for commissioning in **FY 2026-27**.
* **The EOPO Project:** Engineering work has commenced on the **EOPO (Ethylene Oxide/Propylene Oxide)** project, a long-term growth initiative designed to broaden the product portfolio.
* **Operational Efficiency:** The company has achieved a **50% reduction** in lab turnaround times for high-volume products and significant reductions in batch cycle times through data-driven process enhancements and the installation of new raw material storage tanks.
---
### **Core Business Verticals & Market Applications**
The company’s business model is centered on **customer-driven innovation**, with a portfolio characterized by tailor-made solutions transitioned from lab to commercial scale within a **90-day window**.
* **Energy & Oilfield (Strategic Core):** Produces **PPDs**, **VII** (Viscosity Index Improvers), and **H2S Scavengers**. Despite temporary tender fluctuations in **2026**, this remains a primary growth driver, particularly in the **Middle East and North Africa**.
* **Agrochemicals:** Provides emulsifiers and dispersing agents for **SC, WDG, and OD** formulations. This segment achieved **50% sales growth** in **FY 2024-25**, driven by a shift toward water-based and powder-grade surfactants.
* **Home & Personal Care:** Offers biodegradable surfactants and **EO-free** emulsifiers. Volume growth exceeded **35%** in **FY 2023-24**, led by oleoresin solubilizers meeting stringent global purity standards.
* **Paints, Pigments & Coatings:** Supplies **APEO-free** emulsifiers and pigment stabilizers. This vertical saw **20% volume growth** in **FY 2024-25**, supplying nearly all major Indian emulsion units.
* **Emerging Frontiers:** The company is actively researching product development for **Electric Vehicles (EVs) and batteries** to capitalize on the global energy transition.
---
### **Research, Development & Sustainability**
Innovation is the primary driver of the company’s longevity, with **R&D expenditure** ranging between **0.80% and 1.41% of turnover** (**₹2.29 crore** recurring).
* **Technical Capabilities:** Expertise in scaling complex chemical syntheses for extreme operating environments, particularly in the upstream oil sector.
* **Digital Transformation:** Implementation of **AI models** for predictive maintenance and production data analysis to optimize yields.
* **Green Chemistry:** Focus on **"Goal Zero"** for effluents and developing low-VOC, biodegradable alternatives.
* **Environmental Tech:** Utilizes **Submersible Ultra-Filtration (SUF)** and closed-loop vacuum systems to reduce water consumption by **2,100 KL/month**. The company holds **ISO 14001:2018** and **ISO 45001:2018** certifications.
---
### **Financial Performance & Capital Structure**
The company demonstrated a significant turnaround in **FY 2024-25**, characterized by a **38% revenue increase** and a return to a **debt-free balance sheet** (excluding working capital).
**Consolidated Financial Summary:**
| Metric | FY 2024-25 | FY 2023-24 | Growth (%) |
| :--- | :--- | :--- | :--- |
| **Revenue from Operations** | **₹ 181.4 crore** | **₹ 131.6 crore** | **38%** |
| **EBITDA** | **₹ 18.92 crore** | **₹ 12.56 crore** | **50.6%** |
| **Profit Before Tax (PBT)** | **₹ 6.9 crore** | **Marginal** | **N/A** |
| **Gross Margin** | **36%** | **36%** | **Steady** |
**Liquidity & Debt Position (as of March 31, 2025):**
* **Adjusted Net Debt:** Reduced to **₹3.96 crore** from **₹12.64 crore** year-on-year.
* **Net Debt to Equity Ratio:** Improved to **0.02**.
* **Credit Rating:** Upgraded by **CRISIL** in July 2025 to **BBB-/Stable**, though the company later voluntarily withdrew ratings in **April 2026** as sanctioned limits fell below external rating requirements.
* **Foreign Exchange:** Strong net earner with **₹54.84 crore** in earnings against **₹8.78 crore** in outgo (FY24).
---
### **Corporate Structure & Strategic Alliances**
The company operates through a network of subsidiaries and high-value partnerships:
* **Subsidiary:** **Dai-ichi Gosei Chemicals (India) Limited**.
* **Joint Venture:** **ChampionX Dai-ichi India Private Limited (CXDI)**, a **50:50** JV with **ChampionX Corporation, USA**. The company supplies up to **₹50 Crores** of raw materials annually to this JV.
* **Related Party Sourcing:** Procurement arrangement with **Indian Oxides and Chemicals Private Limited (IOCL)** for up to **₹50 Crores**.
**Leadership Succession (Effective April 1, 2026):**
* **Ms. Meher Vakil Taff:** Transitioning to **Vice-Chairperson, CEO, and Managing Director**.
* **Mrs. Shernaz Vakil:** Continuing as **Chairperson & Whole-time Director** (forgoing FY27 incentives).
---
### **Risk Factors & Mitigation**
* **Market Competition:** Facing "throw-away prices" and dumping from **Chinese manufacturers** with excess capacity. The company mitigates this through the **"China + 1" strategy** and focusing on high-contribution specialty niches.
* **Macroeconomic Headwinds:** Sluggish demand in **Europe and the US** due to inflation and recessionary pressures.
* **Regulatory & Legal:**
* Ongoing appeals against a **₹2.17 crore CGST order** and income tax assessments for **AY 2024-25**.
* Non-recurring impact of **₹20 lakhs** in **Q3 FY 2026** due to new **Labour Code** implementations.
* **Historical Recovery:** The **2020 Dahej fire** resulted in a **₹49.32 crore** loss; however, the final insurance settlement of **₹20.58 crore** (received Sept 2023) and the completion of the new plant have stabilized operations.